Developer docs
API playgroundTry for free, no card

Search company profiles

c-LEcta

Full company profile

uuid0006afj

Namestring
c-LEcta
Legal namestring
c-LEcta GmbH
Websiteurl
c-lecta.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

c-LEcta GmbH is a Leipzig, Germany-based biotechnology company founded in 2004 as a spin-off from the University of Leipzig, specializing in engineered enzyme products and microbial production strains for the pharmaceutical and food industries. Its core technology is the proprietary ENESYZ enzyme engineering platform, which combines bioinformatics, AI-guided directed evolution, and a library of 5,000+ preselected microbial strains to deliver targeted enzyme engineering supported by three expression systems (E. coli, Pichia pastoris, and a proprietary endotoxin-free Bacillus platform). The product portfolio spans GMP-grade Denarase endonuclease for viral vector manufacturing, CellTrypase for cell dissociation in cell and gene therapy workflows, NuCLEANase (food and tech grades), Acrylerase for acrylamide reduction in coffee, the Plug & Play Biocats collection for API synthesis, Natural Sweetener technology (Stevia RebM), and licensed products (Acrylaway HighT to Novozymes, OptiPhos Plus phytase via Huvepharma, exclusive Cellobiose enzymes for SAVANNA Ingredients).

The company operates three revenue streams: direct enzyme product sales to pharma and food manufacturers, licensing royalties and co-marketing arrangements with industrial partners, and contract enzyme development services. It serves more than 400 customers in over 40 countries through enterprise field sales plus regional distributors in Turkey, China, India, and the US, with a US warehouse operational since 2023. In April 2022, Kerry Group acquired a 92% majority stake; c-LEcta is the operator of the Kerry Biotechnology Centre (opened 2025) and is currently being fully integrated under the Kerry brand through 2026. c-LEcta reports 130+ employees globally and held ISO 9001, EXCiPACT, ANSI NSF 363, EU GMP, US FDA Drug Master File (Denarase), FDA GRAS (NuCLEANase), kosher, and halal certifications, with revenue reaching €10M for the first time in 2020.

Short descriptiontext

c-LEcta is a Leipzig-based biotechnology company that engineers and manufactures enzyme products (notably Denarase, CellTrypase, NuCLEANase, Acrylerase) for pharmaceutical and food industry customers in over 40 countries, operating as a Kerry Group company and operator of the Kerry Biotechnology Centre.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLeipzig, Germany
HQ citystring
Leipzig
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
industrial enzyme products, pharmaceutical bioprocessing enzymes, food grade enzymes, biocatalysis engineering services, GMP enzyme manufacturing
Industry5 codes
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAOAH
Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat)
SECONDARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYAFAJAJAC
Beverage Fermentation Cultures (Beer, Wine, Cider, Kombucha, Fermented Soft Drinks)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
NAICS code3 codes
  • Food Manufacturing311
  • Pharmaceutical Preparation Manufacturing325412
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
SIC code3 codes
  • Industrial Organic Chemicals2860
  • Medicinal Chemicals & Botanical Products2833
  • Food And Kindred Products2000
Product category
Industrial Enzymes
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Enzyme Product Sales
TypeOne Time License
Description

Sale of proprietary enzyme products including Denarase, CellTrypase, Acrylerase, NuCLEANase, and others for pharmaceutical and food industry applications. Products are sold directly and through distributors globally.

c-lecta.com
2Licensing Royalties
TypeLicensing Royalties
Description

Licensed technologies such as Acrylaway HighT to Novozymes, phytase to Huvepharma (OptiPhos Plus), and co-marketing arrangements with partners like ANKA.

c-lecta.com
3Contract Development Services
TypeProfessional Services
Description

Enzyme development services including custom enzyme engineering and process development for industry partners.

c-lecta.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Denarase®
Description

GMP endonuclease for viral vector manufacturing, recombinantly produced from Serratia marcescens

c-lecta.com
+6 more records
Core offering1 text field

c-LEcta develops, produces and distributes proprietary enzyme products for the pharmaceutical and food industries, manufactured using the ENESYZ engineering platform across three microbial expression hosts. The company also sells licensed enzymes through partners and offers custom enzyme development and bioprocess services to industry customers in more than 40 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Acrylamide reduction up to 90% in soluble coffee applications
+4 more records
Product overview1 text field

c-LEcta is a biotechnology company specializing in enzyme products for the pharmaceutical and food industries. The product portfolio consists of two main categories: Pharma products (Denarase®, Denarase® High Salt, Denarase® ELISA Kit, CellTrypase, and Plug & Play Biocats®) and Food products (Acrylerase®, NuCLEANase® food grade, Natural Sweetener, Acrylaway HighT, and Cellobiose), plus industrial products (Phytase and NuCLEANase® tech grade). The ENESYZ® technology platform enables development of customized enzymes and microbial production strains. Products are manufactured using proprietary production processes in Bacillus, E. coli, and Pichia expression platforms.

Product and service13 records
1Denarase®
CategoryPharmaceutical bioprocessing enzymes
Description

A recombinantly produced endonuclease from Serratia marcescens for degradation of undesired DNA and RNA during manufacturing of biopharmaceutical products, specifically viral vectors. GMP-compliant with ≥99% purity, used by more than 150 customers in 30+ countries and in 4 commercial plus 40+ clinical phase I-III viral vector manufacturing processes.

2Denarase® High Salt
CategoryPharmaceutical bioprocessing enzymes
Description

An engineered version of Denarase with improved salt and pH tolerance, retaining activity at higher salt concentrations. Optimal for nucleic acid removal in biomanufacturing processes that benefit from elevated salt conditions, with a GMP grade launched in March 2025 for clinical and commercial-stage processes.

3Denarase® ELISA Kit
CategoryPharmaceutical assay kits
Description

Quantitative in-vitro detection ELISA kit for Serratia marcescens endonuclease (including Denarase and Benzonase) in biopharmaceutical process samples, 15-50x more sensitive than conventional kits.

4CellTrypase
CategoryPharmaceutical bioprocessing enzymes
Description

A GMP-compliant, animal origin-free recombinant trypsin-like enzyme derived from Fusarium oxysporum for gentle and efficient cell dissociation in biopharmaceutical manufacturing and research. Manufactured with ≥95% purity in the GMP-certified Leipzig facility and usable as a direct replacement for animal-derived or recombinant trypsin solutions in viral vector, vaccine, stem cell, tissue engineering and cell banking workflows.

5Plug & Play Biocats®
CategoryPharmaceutical biocatalysis enzymes
Description

Selection of industrially relevant, prequalified enzymes for the pharma and fine chemicals sector, including nitrilases, transaminases, alcohol dehydrogenases, esterases and NAD(P)H oxidases. Used for synthesis of active pharmaceutical ingredients including cholesterol-lowering drugs, cancer medications and pain relievers.

6Acrylerase®
CategoryFood grade enzymes
Description

Food-grade amidase for highly efficient acrylamide degradation (up to 90%) in soluble coffee, coffee concentrates and coffee surrogates. Jointly developed and co-marketed with ANKA.

7NuCLEANase® food grade
CategoryFood grade enzymes
Description

Highly active nuclease from Serratia marcescens produced via GRAS Bacillus sp. for removal of residual host DNA in food enzymes, fermentation products and alternative proteins. Degrades all forms of DNA and RNA into 5-8 base pair nucleotides and received positive GRAS evaluation from the US FDA (GRN No.1146).

8Natural Sweetener
CategoryFood ingredient enzymes
Description

Enzymatic technology for producing natural high-intensity sweeteners (RebM) from Stevia via multi-enzyme biotransformation, enabling large-scale production at competitive costs. Marketed in partnership with a leading food additives provider.

9Acrylaway HighT
CategoryFood grade enzymes (licensed)
Description

Thermoactive asparaginase developed by c-LEcta and licensed to Novozymes for reduction of acrylamide formation in foods. Active at high temperatures (80-100°C), making it suitable for fried potatoes, cornflakes and coffee applications.

10Cellobiose
CategoryFood ingredient enzymes
Description

Functional sugar produced from beet sugar using enzyme cascade technology, with prebiotic effect, calorie reduction and improved texture and flavor profile. Developed exclusively for Pfeifer & Langen / SAVANNA Ingredients GmbH under co-marketing for novel food applications.

11Phytase
CategoryAnimal feed enzymes
Description

Feed enzyme that releases phosphate from phytic acid in plants, improving utilization of zinc, calcium and trace elements. Marketed as the most thermostable phytase on the market under the OptiPhos® Plus brand by partner Huvepharma for animal feed applications.

12NuCLEANase® tech grade
CategoryIndustrial / technical enzymes
Description

High-performance endonuclease for industrial applications including biofilm removal in laundry detergents, cleaning solutions and other technical processes, providing a cost-efficient solution for degradation of all forms of nucleic acids.

13Custom enzyme engineering and process development services
CategoryContract research and development services
Description

Contract enzyme development and bioprocess services delivered using the ENESYZ platform for industry partners, covering enzyme engineering, microbial strain development and process scale-up. Documented outcomes include more than 50 enzyme engineering projects with greater than 90% technical success rate over 18 years.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint development and co-marketing partner for Acrylerase enzyme product. ANKA provides laboratory and pilot facilities for customer application support and industrial implementation.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Novozymes licenses Acrylaway HighT asparaginase enzyme from c-LEcta for distribution in food applications. c-LEcta developed the thermoactive asparaginase for acrylamide reduction.

Strategic tierMinorTypeOEM/ Whitelabel/ Licensing Partner
Description

Huvepharma distributes c-LEcta's phytase enzyme under the brand OptiPhos Plus for animal feed applications. Phytase is the most thermostable enzyme on the market.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Exclusive enzyme producer for cellobiose enzymes developed for SAVANNA Ingredients. c-LEcta developed corresponding enzymes exclusively for cellobiose production from beet sugar. SAVANNA registers Cellobiose as novel food and markets it.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Expansion of cooperation with industry partners including BASF (among others Symrise, DSM, Thyssen Krupp) starting 2009 for enzyme technology partnerships.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor in Turkey providing local support and reliable product deliveries.

7China Distributor
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor in China providing local support and reliable product deliveries.

c-lecta.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor in India providing local support and reliable product deliveries.

9USA Distributor
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regional distributor in USA providing local support and reliable product deliveries. US warehouse established for direct delivery.

c-lecta.com
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Long-standing partnerships with European contract manufacturers (CMOs) for large-scale industrial enzyme production. Partners follow robust, sustainable production processes with appropriate certified quality standards.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

US-based enzyme engineering company using directed evolution and CodeEvolver platform for pharmaceutical and industrial enzyme applications. Comparable technology approach (directed evolution) with overlap in pharma enzyme markets.

TypeBroad incumbent
Description

Global nutrition and health company with significant enzyme and ingredient capabilities across food, feed, and personal care. Operates at much larger scale than c-LEcta with overlapping customers in food enzyme applications.

3AB Enzymes (ABF Ingredients)
TypeDirect peer
Description

Specialty enzyme manufacturer focused on industrial enzyme applications in food, beverage, and starch processing. Closely comparable business model as a focused enzyme product company with GMP manufacturing capabilities.

4Amano Enzyme
TypeDirect peer
Description

Japanese specialty enzyme manufacturer producing enzymes for food, pharmaceutical, and diagnostic applications. Directly comparable as an enzyme-focused product company with similar customer base in food and pharma industries.

TypeOthers
Description

c-LECTa's 92% parent company and global taste and nutrition partner for food, beverage, and pharma markets. As the acquiring parent and integration partner, Kerry is both an enabling ecosystem participant and indirect competitor through its broader ingredient portfolio.

TypeBroad incumbent
Description

Through its acquisition of DuPont Nutrition & Biosciences, IFF is a major enzyme producer serving food, beverage, and industrial markets. A broad incumbent that competes with c-LEcta across multiple enzyme application categories.

TypeDirect peer
Description

World's largest industrial enzyme company with overlapping food and pharma enzyme portfolios. c-LECTa's Acrylaway HighT is licensed to Novozymes for distribution, demonstrating direct product overlap and competitive positioning in the enzyme industry.

TypeBroad incumbent
Description

Global chemical company with enzyme and biotechnology operations. Has historic collaboration with c-LEcta dating to 2009 for enzyme technology partnerships, and operates broadly in food, feed, and industrial enzyme markets.

TypeBroad incumbent
Description

Life sciences conglomerate whose Sigma-Aldrich division sells Benzonase, the primary competitor to c-LECTa's Denarase. Direct competitive overlap in bioprocessing enzymes used by viral vector and gene therapy manufacturers.

TypeEmerging player
Description

German industrial biotech company developing specialty enzymes and bioactive compounds with proprietary enzyme discovery platform. Direct geographic and technological peer with similar focus on enzyme engineering for industrial applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

c-LEcta

Industrial Enzymesc-lecta.com

c-LEcta is a Leipzig-based biotechnology company that engineers and manufactures enzyme products (notably Denarase, CellTrypase, NuCLEANase, Acrylerase) for pharmaceutical and food industry customers in over 40 countries, operating as a Kerry Group company and operator of the Kerry Biotechnology Centre.

What c-LEcta does

c-LEcta GmbH is a Leipzig, Germany-based biotechnology company founded in 2004 as a spin-off from the University of Leipzig, specializing in engineered enzyme products and microbial production strains for the pharmaceutical and food industries. Its core technology is the proprietary ENESYZ enzyme engineering platform, which combines bioinformatics, AI-guided directed evolution, and a library of 5,000+ preselected microbial strains to deliver targeted enzyme engineering supported by three expression systems (E. coli, Pichia pastoris, and a proprietary endotoxin-free Bacillus platform). The product portfolio spans GMP-grade Denarase endonuclease for viral vector manufacturing, CellTrypase for cell dissociation in cell and gene therapy workflows, NuCLEANase (food and tech grades), Acrylerase for acrylamide reduction in coffee, the Plug & Play Biocats collection for API synthesis, Natural Sweetener technology (Stevia RebM), and licensed products (Acrylaway HighT to Novozymes, OptiPhos Plus phytase via Huvepharma, exclusive Cellobiose enzymes for SAVANNA Ingredients).

The company operates three revenue streams: direct enzyme product sales to pharma and food manufacturers, licensing royalties and co-marketing arrangements with industrial partners, and contract enzyme development services. It serves more than 400 customers in over 40 countries through enterprise field sales plus regional distributors in Turkey, China, India, and the US, with a US warehouse operational since 2023. In April 2022, Kerry Group acquired a 92% majority stake; c-LEcta is the operator of the Kerry Biotechnology Centre (opened 2025) and is currently being fully integrated under the Kerry brand through 2026. c-LEcta reports 130+ employees globally and held ISO 9001, EXCiPACT, ANSI NSF 363, EU GMP, US FDA Drug Master File (Denarase), FDA GRAS (NuCLEANase), kosher, and halal certifications, with revenue reaching €10M for the first time in 2020.

c-LEcta firmographics

Firmographics
Name
c-LEcta
Legal name
c-LEcta GmbH
Website
https://c-lecta.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
c-LEcta is a Leipzig-based biotechnology company that engineers and manufactures enzyme products (notably Denarase, CellTrypase, NuCLEANase, Acrylerase) for pharmaceutical and food industry customers in over 40 countries, operating as a Kerry Group company and operator of the Kerry Biotechnology Centre.
Ownership category
akta.pro rank

c-LEcta industry classification

Industry
Product category
Industrial Enzymes
NAICS
Food Manufacturing (311), Pharmaceutical Preparation Manufacturing (325412), Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253)
SIC
Industrial Organic Chemicals (2860), Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
akta.pro industry
PRIMARYEUAAAIAL
Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAOAH
Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat)
SECONDARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
SECONDARYAFAJAJAC
Beverage Fermentation Cultures (Beer, Wine, Cider, Kombucha, Fermented Soft Drinks)
Agriculture & Food Production/Food Ingredients & Additives/Cultures & Fermentation Ingredients (Starter Cultures, Probiotics, Yeast)
SECONDARYEUAAAIAJ
Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)

Keywords

  • Industrial enzyme products
  • Pharmaceutical bioprocessing enzymes
  • Food grade enzymes
  • Biocatalysis engineering services
  • GMP enzyme manufacturing

Where c-LEcta is headquartered

Location

Headquarters

HQ city
Leipzig
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

c-LEcta business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

  1. Enzyme Product Sales: Sale of proprietary enzyme products including Denarase, CellTrypase, Acrylerase, NuCLEANase, and others for pharmaceutical and food industry applications. Products are sold directly and through distributors globally.
  2. Licensing Royalties: Licensed technologies such as Acrylaway HighT to Novozymes, phytase to Huvepharma (OptiPhos Plus), and co-marketing arrangements with partners like ANKA.
  3. Contract Development Services: Enzyme development services including custom enzyme engineering and process development for industry partners.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

c-LEcta product offering

Product offering

Core offering

c-LEcta develops, produces and distributes proprietary enzyme products for the pharmaceutical and food industries, manufactured using the ENESYZ engineering platform across three microbial expression hosts. The company also sells licensed enzymes through partners and offers custom enzyme development and bioprocess services to industry customers in more than 40 countries.

Product overview

c-LEcta is a biotechnology company specializing in enzyme products for the pharmaceutical and food industries. The product portfolio consists of two main categories: Pharma products (Denarase®, Denarase® High Salt, Denarase® ELISA Kit, CellTrypase, and Plug & Play Biocats®) and Food products (Acrylerase®, NuCLEANase® food grade, Natural Sweetener, Acrylaway HighT, and Cellobiose), plus industrial products (Phytase and NuCLEANase® tech grade). The ENESYZ® technology platform enables development of customized enzymes and microbial production strains. Products are manufactured using proprietary production processes in Bacillus, E. coli, and Pichia expression platforms.

Differentiator

Problem solved

Functional benefit

Brands

  • Denarase®: GMP endonuclease for viral vector manufacturing, recombinantly produced from Serratia marcescens
  • CellTrypase
  • NuCLEANase®
  • Acrylerase®
  • Acrylaway®
  • Plug & Play Biocats®
  • ENESYZ®

Products and services

  • Denarase® A recombinantly produced endonuclease from Serratia marcescens for degradation of undesired DNA and RNA during manufacturing of biopharmaceutical products, specifically viral vectors. GMP-compliant with ≥99% purity, used by more than 150 customers in 30+ countries and in 4 commercial plus 40+ clinical phase I-III viral vector manufacturing processes.
  • Denarase® High Salt An engineered version of Denarase with improved salt and pH tolerance, retaining activity at higher salt concentrations. Optimal for nucleic acid removal in biomanufacturing processes that benefit from elevated salt conditions, with a GMP grade launched in March 2025 for clinical and commercial-stage processes.
  • Denarase® ELISA Kit Quantitative in-vitro detection ELISA kit for Serratia marcescens endonuclease (including Denarase and Benzonase) in biopharmaceutical process samples, 15-50x more sensitive than conventional kits.
  • CellTrypase A GMP-compliant, animal origin-free recombinant trypsin-like enzyme derived from Fusarium oxysporum for gentle and efficient cell dissociation in biopharmaceutical manufacturing and research. Manufactured with ≥95% purity in the GMP-certified Leipzig facility and usable as a direct replacement for animal-derived or recombinant trypsin solutions in viral vector, vaccine, stem cell, tissue engineering and cell banking workflows.
  • Plug & Play Biocats® Selection of industrially relevant, prequalified enzymes for the pharma and fine chemicals sector, including nitrilases, transaminases, alcohol dehydrogenases, esterases and NAD(P)H oxidases. Used for synthesis of active pharmaceutical ingredients including cholesterol-lowering drugs, cancer medications and pain relievers.
  • Acrylerase® Food-grade amidase for highly efficient acrylamide degradation (up to 90%) in soluble coffee, coffee concentrates and coffee surrogates. Jointly developed and co-marketed with ANKA.
  • NuCLEANase® food grade Highly active nuclease from Serratia marcescens produced via GRAS Bacillus sp. for removal of residual host DNA in food enzymes, fermentation products and alternative proteins. Degrades all forms of DNA and RNA into 5-8 base pair nucleotides and received positive GRAS evaluation from the US FDA (GRN No.1146).
  • Natural Sweetener Enzymatic technology for producing natural high-intensity sweeteners (RebM) from Stevia via multi-enzyme biotransformation, enabling large-scale production at competitive costs. Marketed in partnership with a leading food additives provider.
  • Acrylaway HighT Thermoactive asparaginase developed by c-LEcta and licensed to Novozymes for reduction of acrylamide formation in foods. Active at high temperatures (80-100°C), making it suitable for fried potatoes, cornflakes and coffee applications.
  • Cellobiose Functional sugar produced from beet sugar using enzyme cascade technology, with prebiotic effect, calorie reduction and improved texture and flavor profile. Developed exclusively for Pfeifer & Langen / SAVANNA Ingredients GmbH under co-marketing for novel food applications.
  • Phytase Feed enzyme that releases phosphate from phytic acid in plants, improving utilization of zinc, calcium and trace elements. Marketed as the most thermostable phytase on the market under the OptiPhos® Plus brand by partner Huvepharma for animal feed applications.
  • NuCLEANase® tech grade High-performance endonuclease for industrial applications including biofilm removal in laundry detergents, cleaning solutions and other technical processes, providing a cost-efficient solution for degradation of all forms of nucleic acids.
  • Custom enzyme engineering and process development services Contract enzyme development and bioprocess services delivered using the ENESYZ platform for industry partners, covering enzyme engineering, microbial strain development and process scale-up. Documented outcomes include more than 50 enzyme engineering projects with greater than 90% technical success rate over 18 years.

Quantifiable outcome

  • Acrylamide reduction up to 90% in soluble coffee applications
  • +4 more outcomes

Companies that use c-LEcta

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

c-LEcta technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

c-LEcta partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • ANKAcoreStrategic or Co-development PartnerJoint development and co-marketing partner for Acrylerase enzyme product. ANKA provides laboratory and pilot facilities for customer application support and industrial implementation.
  • NovozymescoreOEM/ Whitelabel/ Licensing PartnerNovozymes licenses Acrylaway HighT asparaginase enzyme from c-LEcta for distribution in food applications. c-LEcta developed the thermoactive asparaginase for acrylamide reduction.
  • HuvepharmaminorOEM/ Whitelabel/ Licensing PartnerHuvepharma distributes c-LEcta's phytase enzyme under the brand OptiPhos Plus for animal feed applications. Phytase is the most thermostable enzyme on the market.
  • Pfeifer & Langen / SAVANNA Ingredients GmbHcoreStrategic or Co-development PartnerExclusive enzyme producer for cellobiose enzymes developed for SAVANNA Ingredients. c-LEcta developed corresponding enzymes exclusively for cellobiose production from beet sugar. SAVANNA registers Cellobiose as novel food and markets it.
  • BASFminorStrategic or Co-development PartnerExpansion of cooperation with industry partners including BASF (among others Symrise, DSM, Thyssen Krupp) starting 2009 for enzyme technology partnerships.
  • Turkey DistributorminorChannel Partner/ Reseller/ DistributorRegional distributor in Turkey providing local support and reliable product deliveries.
  • China DistributorminorChannel Partner/ Reseller/ DistributorRegional distributor in China providing local support and reliable product deliveries.
  • India DistributorminorChannel Partner/ Reseller/ DistributorRegional distributor in India providing local support and reliable product deliveries.
  • USA DistributorminorChannel Partner/ Reseller/ DistributorRegional distributor in USA providing local support and reliable product deliveries. US warehouse established for direct delivery.
  • European Contract ManufacturerscoreImplementation/ SI/ Consulting PartnerLong-standing partnerships with European contract manufacturers (CMOs) for large-scale industrial enzyme production. Partners follow robust, sustainable production processes with appropriate certified quality standards.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

c-LEcta competitors and assessment

Company assessment

Emerging players

  • Codexis: US-based enzyme engineering company using directed evolution and CodeEvolver platform for pharmaceutical and industrial enzyme applications. Comparable technology approach (directed evolution) with overlap in pharma enzyme markets.
  • BRAIN Biotech: German industrial biotech company developing specialty enzymes and bioactive compounds with proprietary enzyme discovery platform. Direct geographic and technological peer with similar focus on enzyme engineering for industrial applications.

Broad incumbents

  • DSM-Firmenich: Global nutrition and health company with significant enzyme and ingredient capabilities across food, feed, and personal care. Operates at much larger scale than c-LEcta with overlapping customers in food enzyme applications.
  • IFF (International Flavors & Fragrances): Through its acquisition of DuPont Nutrition & Biosciences, IFF is a major enzyme producer serving food, beverage, and industrial markets. A broad incumbent that competes with c-LEcta across multiple enzyme application categories.
  • BASF: Global chemical company with enzyme and biotechnology operations. Has historic collaboration with c-LEcta dating to 2009 for enzyme technology partnerships, and operates broadly in food, feed, and industrial enzyme markets.
  • Merck KGaA: Life sciences conglomerate whose Sigma-Aldrich division sells Benzonase, the primary competitor to c-LECTa's Denarase. Direct competitive overlap in bioprocessing enzymes used by viral vector and gene therapy manufacturers.

Direct peers

  • AB Enzymes (ABF Ingredients): Specialty enzyme manufacturer focused on industrial enzyme applications in food, beverage, and starch processing. Closely comparable business model as a focused enzyme product company with GMP manufacturing capabilities.
  • Amano Enzyme: Japanese specialty enzyme manufacturer producing enzymes for food, pharmaceutical, and diagnostic applications. Directly comparable as an enzyme-focused product company with similar customer base in food and pharma industries.
  • Novonesis (formerly Novozymes): World's largest industrial enzyme company with overlapping food and pharma enzyme portfolios. c-LECTa's Acrylaway HighT is licensed to Novozymes for distribution, demonstrating direct product overlap and competitive positioning in the enzyme industry.

Others

  • Kerry Group: c-LECTa's 92% parent company and global taste and nutrition partner for food, beverage, and pharma markets. As the acquiring parent and integration partner, Kerry is both an enabling ecosystem participant and indirect competitor through its broader ingredient portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

c-LEcta social profiles

Digital presence

c-LEcta compliance and trust

Trust signal

Compliance9 records

c-LEcta financial estimates

Financial estimate

Revenue estimate

Valuation estimate

c-LEcta leadership team

Management profile

Number of profiles

Profiles8 records

c-LEcta funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

c-LEcta M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about c-LEcta

What does c-LEcta do?

c-LEcta develops, produces and distributes proprietary enzyme products for the pharmaceutical and food industries, manufactured using the ENESYZ engineering platform across three microbial expression hosts. The company also sells licensed enzymes through partners and offers custom enzyme development and bioprocess services to industry customers in more than 40 countries.

Is c-LEcta a public or private company?

c-LEcta is a private company. It is classified as corporate owned and is currently operating.

When was c-LEcta founded?

c-LEcta was founded in 2004. It employs 51 to 100 people.

Where is c-LEcta based?

c-LEcta is headquartered in Leipzig, Germany, in the Europe region.

How does c-LEcta make money?

Three revenue lines are on record. Enzyme Product Sales are the primary driver. The others are licensing Royalties and contract Development Services.

Who are c-LEcta's main competitors?

Emerging players on record are Codexis and BRAIN Biotech. Broad incumbents are DSM-Firmenich, IFF (International Flavors & Fragrances), BASF and Merck KGaA. Direct peers are AB Enzymes (ABF Ingredients), Amano Enzyme and Novonesis (formerly Novozymes). Kerry Group is listed as an others.

Does c-LEcta have an API?

No public API is recorded for c-LEcta.

What industry is c-LEcta in?

c-LEcta's product category is Industrial Enzymes. Its primary akta.pro industry code is EUAAAIAL, Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids), with a secondary code of CRADAOAH, Enzymes & Processing Aids (Baking, Brewing, Dairy, Meat). Its NAICS code is 311 and its SIC code is 2860.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comAlternative Proteins Market Value Chain and Forecast Analysis 2026 to 2035InsightAce Analytic released a market assessment report forecasting the global alternative proteins market to grow from USD 18.01 billion in 2025 to USD 61.69 billion by 2035, at a 13.70% CAGR. North America is expected to dominate the market due to sustainable protein production emphasis and vegan population growth, while the Asia Pacific region is anticipated to expand rapidly. Recent collaborations include Kerry Inc.'s acquisition of 92% of c-LEcta GmbH and Archer Daniels Midland opening a plant-based protein research facility in Singapore.foodnavigator.comKerry talks c-LEcta acquisition: ‘Biotechnology, synthetic biology and precision fermentation are radically transforming food’Kerry Taste & Nutrition acquired a majority stake in German biotech c-LEcta, which develops enzymes and fermentation technologies. The deal expands Kerry's biotech capabilities and will leverage Kerry's sales teams to enter the pharma market. Kerry also acquired Mexican enzyme manufacturer Enmex.C-Lectac-LEcta announces that it has reached agreement to be acquired by Kerry Groupc-LEcta has reached an agreement to be acquired by Kerry Group, which will take a majority shareholding in the biotechnology company. This strategic combination aims to accelerate Kerry’s innovation capabilities in enzyme engineering and fermentation while enabling c-LEcta to access global markets through Kerry's extensive network.FinSMEsBiotech Company c-LEcta Closes Financing Roundc-LEcta, a Leipzig-based biotech firm, closed an undisclosed financing round with Capricorn Venture Partners and bm|t. The funds will scale operations and food ingredient manufacturing capacity to commercial production. The company employs about 60 people.PR Newswirec-LEcta and Leading Ingredient Company Develop Process to Expand Production of Plant-based Sweetener With Sugar-like Tastec-LEcta and a leading ingredient company developed an enzymatic process to expand production of a plant-based sweetener with a sugar-like taste. The sweetener is FDA GRAS, suitable for zero-calorie beverages and foods, and the process uses fewer resources. Commercialization could expand c-LEcta's sales and product portfolio.